Allen Investment Management LLC Buys 64,418 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Allen Investment Management LLC increased its stake in UnitedHealth Group by 6.7%, now owning approximately 1,030,968 shares valued at about $539.97 million.
• The company announced a quarterly dividend of $2.21, up from the previous $2.10, reflecting an annualized dividend yield of 3.15%.
• Analyst ratings show a consensus "Moderate Buy" for UnitedHealth Group, with a target price adjusted down to $392.29 amidst various changes from major firms.

Allen Investment Management LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,030,968 shares of the healthcare conglomerate's stock after purchasing an additional 64,418 shares during the quarter. UnitedHealth Group comprises 6.3% of Allen Investment Management LLC's holdings, making the stock its 5th largest holding. Allen Investment Management LLC owned 0.11% of UnitedHealth Group worth $539,969,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently added to or reduced their stakes in the company. Marshall & Sterling Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Kapitalo Investimentos Ltda purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $41,000. Finally, Copia Wealth Management purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $42,000. Institutional investors own 87.86% of the company's stock.

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. Barclays reissued an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Morgan Stanley dropped their price objective on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a report on Wednesday, May 14th. Oppenheimer dropped their price target on UnitedHealth Group from $600.00 to $400.00 and set an "outperform" rating for the company in a research report on Wednesday, May 14th. Piper Sandler dropped their price target on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research report on Tuesday, June 3rd. Finally, KeyCorp lowered their price objective on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $392.29.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Kristen Gil bought 3,700 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director directly owned 3,818 shares of the company's stock, valued at $1,035,327.06. The trade was a 3,135.59% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have acquired 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $14.22 during trading hours on Tuesday, reaching $267.90. The stock had a trading volume of 26,908,385 shares, compared to its average volume of 11,486,181. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The firm has a 50-day moving average of $300.91 and a 200-day moving average of $422.56. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $243.02 billion, a price-to-earnings ratio of 11.22, a PEG ratio of 1.39 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $5.16 by ($1.08). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the firm earned $6.80 earnings per share. The business's revenue for the quarter was up 12.9% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.30%. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.